Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) have earned a consensus rating of “Buy” from the nine brokerages that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price target among analysts […]![]()
Merit Medical Systems, Inc. (MMSI) Receives Consensus Recommendation of “Buy” from Brokerages
↧
↧
THL Credit, Inc. (TCRD) Receives Average Rating of “Hold” from Analysts
Shares of THL Credit, Inc. (NASDAQ:TCRD) have received an average recommendation of “Hold” from the ten research firms that are covering the company, Marketbeat reports. Six research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1 year price target among brokerages that […]![]()
↧
Kimco Realty Corporation (KIM) Given Average Recommendation of “Hold” by Brokerages
Kimco Realty Corporation (NYSE:KIM) has received an average recommendation of “Hold” from the twenty research firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, nine have issued a hold rating, eight have issued a buy rating and one has issued a strong buy rating on the […]![]()
↧
Cominar REIT (CUF.UN) Given Average Rating of “Hold” by Brokerages
Shares of Cominar REIT (TSE:CUF.UN) have earned an average recommendation of “Hold” from the seven ratings firms that are currently covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation. The average 1 year target price among analysts that have issued a report on the stock in the […]![]()
↧
Heron Therapeutics, Inc. (HRTX) Rating Increased to Sell at ValuEngine
Heron Therapeutics, Inc. (NASDAQ:HRTX) was upgraded by research analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research note issued on Thursday. A number of other equities research analysts also recently commented on the company. Zacks Investment Research upgraded Heron Therapeutics from a “strong sell” rating to a “hold” rating […]![]()
↧
↧
pdvWireless, Inc. (PDVW) Downgraded by ValuEngine
pdvWireless, Inc. (NASDAQ:PDVW) was downgraded by equities researchers at ValuEngine from a “hold” rating to a “sell” rating in a report issued on Thursday. Separately, Zacks Investment Research raised shares of pdvWireless from a “hold” rating to a “buy” rating and set a $24.00 target price for the company in a research report on Wednesday, […]![]()
↧
Ligand Pharmaceuticals Incorporated (LGND) Raised to Hold at ValuEngine
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday. A number of other equities research analysts also recently commented on the stock. Zacks Investment Research raised shares of Ligand Pharmaceuticals from a “strong sell” rating […]![]()
↧
Novadaq Technologies Inc (NVDQ) Upgraded to “Hold” at ValuEngine
Novadaq Technologies Inc (NASDAQ:NVDQ) (TSE:NDQ) was upgraded by investment analysts at ValuEngine from a “sell” rating to a “hold” rating in a research note issued on Thursday. A number of other analysts have also recently issued reports on the company. First Analysis cut Novadaq Technologies from an “overweight” rating to an “equal weight” rating in […]![]()
↧
Sientra, Inc. (SIEN) Upgraded by ValuEngine to “Hold”
Sientra, Inc. (NASDAQ:SIEN) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a research note issued on Thursday. Several other equities research analysts have also issued reports on SIEN. Zacks Investment Research lowered Sientra from a “hold” rating to a “sell” rating in a report on Wednesday, May […]![]()
↧
↧
Ultragenyx Pharmaceutical Inc. (RARE) Rating Increased to Hold at ValuEngine
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a research note issued on Thursday. Several other research firms have also commented on RARE. SunTrust Banks, Inc. raised their price target on shares of Ultragenyx Pharmaceutical from $100.00 to $105.00 and gave the company […]![]()
↧
Aercap Holdings N.V. (AER) Downgraded to Hold at BidaskClub
Aercap Holdings N.V. (NYSE:AER) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday. AER has been the topic of several other reports. ValuEngine downgraded Aercap Holdings N.V. from a “strong-buy” rating to a “buy” rating in a […]![]()
↧
ValuEngine Upgrades Corindus Vascular Robotics Inc (CVRS) to Hold
Corindus Vascular Robotics Inc (NYSEMKT:CVRS) was upgraded by stock analysts at ValuEngine from a “sell” rating to a “hold” rating in a research note issued on Thursday. Several other brokerages have also recently issued reports on CVRS. B. Riley restated a “buy” rating and set a $3.00 price objective on shares of Corindus Vascular Robotics […]![]()
↧
Harte-Hanks, Inc. (HHS) Downgraded to “Strong Sell” at ValuEngine
Harte-Hanks, Inc. (NYSE:HHS) was downgraded by analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a report released on Thursday. Several other brokerages have also recently issued reports on HHS. Noble Financial cut shares of Harte-Hanks from a “buy” rating to a “hold” rating in a research note on Monday, June […]![]()
↧
↧
ValuEngine Lowers Alliance Resource Partners, L.P. (ARLP) to Buy
Alliance Resource Partners, L.P. (NASDAQ:ARLP) was downgraded by investment analysts at ValuEngine from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Thursday. Several other research analysts have also recently weighed in on the company. BidaskClub raised Alliance Resource Partners, L.P. from a “strong sell” rating to a “sell” […]![]()
↧
Francesca’s Holdings Corporation (FRAN) Cut to “Hold” at ValuEngine
Francesca’s Holdings Corporation (NASDAQ:FRAN) was downgraded by research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued on Thursday. A number of other equities research analysts have also commented on the company. Zacks Investment Research upgraded Francesca’s Holdings Corporation from a “hold” rating to a “buy” rating and […]![]()
↧
Energen Corporation (EGN) Lowered to “Sell” at ValuEngine
Energen Corporation (NYSE:EGN) was downgraded by research analysts at ValuEngine from a “hold” rating to a “sell” rating in a report issued on Thursday. Several other analysts have also issued reports on the company. Scotiabank restated a “buy” rating and issued a $64.00 price objective on shares of Energen Corporation in a research note on […]![]()
↧
Collegium Pharmaceutical, Inc. (COLL) Upgraded to Sell at ValuEngine
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) was upgraded by stock analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Thursday. A number of other equities analysts also recently weighed in on COLL. Zacks Investment Research downgraded Collegium Pharmaceutical from a “buy” rating to a […]![]()
↧
↧
Agios Pharmaceuticals, Inc. (AGIO) Upgraded to Hold by ValuEngine
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) was upgraded by research analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued on Thursday. Several other research firms have also commented on AGIO. Oppenheimer Holdings, Inc. set a $75.00 price objective on shares of Agios Pharmaceuticals and gave the company a “buy” rating […]![]()
↧
Aeglea BioTherapeutics, Inc. (AGLE) Lifted to Sell at ValuEngine
Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) was upgraded by stock analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Thursday. AGLE has been the subject of a number of other reports. Zacks Investment Research raised shares of Aeglea BioTherapeutics from a “hold” rating to […]![]()
↧
ValuEngine Downgrades Deckers Outdoor Corporation (DECK) to Hold
Deckers Outdoor Corporation (NYSE:DECK) was downgraded by ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Thursday. Other analysts have also issued reports about the stock. B. Riley reiterated a “neutral” rating and set a $61.00 target price on shares of Deckers Outdoor Corporation in a report on […]![]()
↧
More Pages to Explore .....
